Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Everest Medicines Announces Commercial Launch and First Prescription for XERAVA® in China 2023-07-27 08:10
YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023 2023-07-27 05:00
Hummingbird Bioscience Initiates HMBD-001 Phase IB Trials in Australia and Partners with Omico to Accelerate Clinical Development 2023-07-27 04:00
PharmAbcine Announces First Patient Dosed in the Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD 2023-07-26 20:00
How MGI Boosts Agrigenomics and Food Sustainability with Sequencing Technology: An Australian Case Study 2023-07-26 19:18
Samsung Biologics Reports Second Quarter 2023 Financial Results 2023-07-26 15:23
China's Yunhong Group furthers global push on full biodegradation 2023-07-26 13:07
Mabwell to Present Clinical Trial Data of 2 Programs at ESMO Congress 2023 2023-07-26 00:00
Fapon Launches the Most Efficient Chemiluminescence Immunoassay Analyzer to Date with Throughput of 900 T/h 2023-07-25 20:07
Solar Biotech Acquires Noblegen 2023-07-25 19:42
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement 2023-07-25 19:30
RemeGen's Telitacicept Shows Significant Promise in Phase II Trial for Primary Sjogren's Syndrome: Findings Published in Prestigious Rheumatology Journal 2023-07-25 16:00
Duopharma Biotech Applauded by Frost & Sullivan for Providing Innovative Healthcare Solutions in the Malaysian Market 2023-07-25 14:00
Fapon to Showcase Innovative Diagnostic and Biopharma Solutions at 2023 AACC Expo 2023-07-24 21:58
Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial 2023-07-24 21:02
Biocon Biologics Announces Positive CHMP Opinion for YESAFILI®, Biosimilar Aflibercept 2023-07-24 18:30
BGI Genomics Global Cervical Cancer Survey Finds Young Women Have Higher Vaccination Rates but 43.5 percent Put off by Pap Smears 2023-07-24 10:30
Insilico Medicine Nominates Preclinical Candidate of Inhalation Solution for ISM001-055, the First Generative AI IPF Drug 2023-07-22 14:37
YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023 2023-07-22 04:30
YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023 2023-07-22 04:30
1 91 92 93 94 95 452